BRIEF-Knight Therapeutics Says Will Have Exclusive Rights To Market And Sell Tenapanor In Canada
March 19, 2018 at 06:36 AM EDT
* KNIGHT THERAPEUTICS - LICENSE AGREEMENT WITH ARDELYX THAT PROVIDES KNIGHT WITH EXCLUSIVE RIGHTS TO COMMERCIALIZE TENAPANOR IN CANADA
